FORMULATIONS OF FLUORINATED STILBENE SUITABLE FOR PET IMAGING

The invention is directed to formulations of lipophilic Amyloid beta ligand stilbene and more particularly to formulations which are capable to be administered parenterally e.g. intravenously, wherein the lipophilic Amyloid beta ligand stilbene is a fluorinated stilbene. Further, the invention is di...

Full description

Saved in:
Bibliographic Details
Main Authors BURKHARD, ANDREAS, BRAUN, RAINER, RICHTER, ANNETT, OLBRICH, CARSTEN, KRAUSE, MICHAEL
Format Patent
LanguageEnglish
French
Published 13.08.2019
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention is directed to formulations of lipophilic Amyloid beta ligand stilbene and more particularly to formulations which are capable to be administered parenterally e.g. intravenously, wherein the lipophilic Amyloid beta ligand stilbene is a fluorinated stilbene. Further, the invention is directed to a method for sterile filtration of formulations suitable for PET imaging of mammals pursuant to the invention. L'invention porte sur des formulations de stilbène ligand de ?-Amyloïde lipophile et plus particulièrement sur des formulations qui peuvent être administrées par voie parentérale, par exemple par voie intraveineuse, le stilbène ligand de ?-Amyloïde lipophile étant un stilbène fluoré. En outre, l'invention porte sur un procédé pour la filtration stérile de formulations appropriées pour l'imagerie par TEP de mammifères conformément à l'invention.
Bibliography:Application Number: CA20122839961